DelphX Announces Warrant Extension

Core Viewpoint - DelphX Capital Markets Inc. is seeking approval from the TSX Venture Exchange to extend the exercise period of certain share purchase warrants by one year, which indicates a strategic move to provide more flexibility for investors [1][2]. Group 1: Warrant Details - The company intends to extend the exercise period of 4,825,715 share purchase warrants, originally exercisable at $0.30 per common share, to August 25, 2026 [2]. - Additionally, 2,825,000 share purchase warrants, exercisable at $0.15 per common share, will also have their exercise period extended to August 30, 2026 [2]. - All other terms and conditions of the warrants will remain unchanged, and the extension is subject to acceptance by the TSX Venture Exchange [3]. Group 2: Related Party Transactions - A total of 1,929,286 warrants are held by parties considered "related parties" of DelphX, making the amendment a "related party transaction" under relevant regulations [4]. - The company can rely on exemptions from formal valuation and minority approval requirements since the fair market value of the warrants does not exceed 25% of DelphX's market capitalization [4]. Group 3: Company Overview - DelphX is focused on developing and distributing next-generation structured products, including collateralized put options (CPOs) and collateralized reference notes (CRNs) [5][8]. - The company enables broker-dealers to offer new private placement securities that provide fixed income and cryptocurrency solutions [5]. - CPOs and CRNs are fully collateralized and held in custody by US Bank, showcasing the company's commitment to security and reliability in its offerings [6][8].